KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Elanco Animal Health (ELAN) Enterprise Value (2017 - 2025)

Elanco Animal Health's Enterprise Value history spans 9 years, with the latest figure at -$545.0 million for Q4 2025.

  • For Q4 2025, Enterprise Value fell 16.45% year-over-year to -$545.0 million; the TTM value through Dec 2025 reached -$545.0 million, down 16.45%, while the annual FY2025 figure was -$545.0 million, 16.45% down from the prior year.
  • Enterprise Value for Q4 2025 was -$545.0 million at Elanco Animal Health, down from -$505.0 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$318.0 million in Q1 2023 and bottomed at -$638.0 million in Q4 2021.
  • The 5-year median for Enterprise Value is -$464.0 million (2022), against an average of -$452.0 million.
  • The largest annual shift saw Enterprise Value surged 58.63% in 2021 before it tumbled 41.16% in 2025.
  • A 5-year view of Enterprise Value shows it stood at -$638.0 million in 2021, then soared by 45.92% to -$345.0 million in 2022, then fell by 2.03% to -$352.0 million in 2023, then plummeted by 32.95% to -$468.0 million in 2024, then decreased by 16.45% to -$545.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Enterprise Value are -$545.0 million (Q4 2025), -$505.0 million (Q3 2025), and -$539.0 million (Q2 2025).